Akoya Biosciences, Inc.
AKYA
Revenue
23.16M
▲4.81M▲26.23%
3 Months ChangeAssets
143.75M
▼-11.01M▼-7.11%
3 Months ChangeLiabilities
121.50M
▼-531.00k▼-0.4351%
3 Months ChangeFree Cash Flow
-21.63M
▼-1.07M▼-5.21%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
Date | Revenue | Cost Of Revenue |
---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
Date | Net Profit/Loss |
---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
Date | Assets | Liabilities |
---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
Date | EPS | EPS (Diluted) |
---|---|---|
Outstanding Shares
Loading...
Date | Outstanding Shares |
---|---|
Recent 8-K/10-Q Filings
2024-10-03
Form 8-K
ID: 0001104659-24-105824
2024-08-06
Form 10-Q
ID: 0001558370-24-010883
2024-08-05
Form 8-K
ID: 0001558370-24-010858
2024-06-04
Form 8-K
ID: 0001104659-24-068236
2024-05-14
Form 10-Q
ID: 0001558370-24-007998
2024-05-13
Form 8-K
ID: 0001558370-24-007957
2024-03-04
Form 8-K
ID: 0001558370-24-002358
2024-01-10
Form 8-K
ID: 0001104659-24-002962
2024-01-08
Form 8-K
ID: 0001104659-24-001980
2023-11-09
Form 10-Q
ID: 0001558370-23-018324